Myriad’s myPath Melanoma Test Receives Medicare
Myriad Genetics Inc., a global leader in personalized medicine, announced that the Medicare administrative contractor Palmetto GBA MolDx has issued a final local coverage determination (LCD) for the myPath Melanoma test to help physicians provide a definitive ...
Laura M. Achilles
As an aesthetician for over 10 years Dermascope was recmmended by my employer at my spa that I work for. I was wondering as a professional are there any special discounts for subscribing to your magazine, I would appreciate any info available. Thank ...